On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
DOI10.1016/J.SPL.2011.02.037zbMATH Open1217.62184OpenAlexW2067453181MaRDI QIDQ544613FDOQ544613
Authors: Bart Mertens, Y. E. M. Van Der Burgt, B. Velstra, W. E. Mesker, Rob A. E. M. Tollenaar, Andre M. Deelder
Publication date: 15 June 2011
Published in: Statistics \& Probability Letters (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.spl.2011.02.037
Recommendations
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
- Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
- A new method for recognition proteomic mass spectrometry data using double-time projections
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Biomedical imaging and signal processing (92C55)
Cites Work
- Random forests
- Title not available (Why is that?)
- Classifier technology and the illusion of progress
- Title not available (Why is that?)
- Two further applications of a model for binary regression
- Exact Principal Component Influence Measures Applied to the Analysis of Spectroscopic Data on Rice
- Stacked regressions
- Organizing a competition on clinical mass spectrometry based proteomic diagnosis
- Downdating: Interdisciplinary Research Between Statistics and Computing
Cited In (3)
- Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications
- A new method for recognition proteomic mass spectrometry data using double-time projections
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
Uses Software
This page was built for publication: On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q544613)